These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24176400)
21. Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents. Lukasik PM; Elabar S; Lam F; Shao H; Liu X; Abbas AY; Wang S Eur J Med Chem; 2012 Nov; 57():311-22. PubMed ID: 23085105 [TBL] [Abstract][Full Text] [Related]
23. Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives. Nascimento-Júnior NM; Mendes TC; Leal DM; Corrêa CM; Sudo RT; Zapata-Sudo G; Barreiro EJ; Fraga CA Bioorg Med Chem Lett; 2010 Jan; 20(1):74-7. PubMed ID: 19963376 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling. Bouchikhi F; Anizon F; Moreau P Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788 [TBL] [Abstract][Full Text] [Related]
25. Microwave assisted tandem Heck-Sonogashira reactions of N,N-di-Boc-protected 6-amino-5-iodo-2-methyl pyrimidin-4-ol in an efficient approach to functionalized pyrido[2,3-d]pyrimidines. Liu Y; Jin S; Wang Z; Song L; Hu Y Org Lett; 2014 Jul; 16(13):3524-7. PubMed ID: 24956126 [TBL] [Abstract][Full Text] [Related]
26. Structure-based discovery of cellular-active allosteric inhibitors of FAK. Tomita N; Hayashi Y; Suzuki S; Oomori Y; Aramaki Y; Matsushita Y; Iwatani M; Iwata H; Okabe A; Awazu Y; Isono O; Skene RJ; Hosfield DJ; Miki H; Kawamoto T; Hori A; Baba A Bioorg Med Chem Lett; 2013 Mar; 23(6):1779-85. PubMed ID: 23414845 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors. Le Corre L; Girard AL; Aubertin J; Radvanyi F; Benoist-Lasselin C; Jonquoy A; Mugniery E; Legeai-Mallet L; Busca P; Le Merrer Y Org Biomol Chem; 2010 May; 8(9):2164-73. PubMed ID: 20401393 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors. Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I. Foucourt A; Hédou D; Dubouilh-Benard C; Désiré L; Casagrande AS; Leblond B; Loäec N; Meijer L; Besson T Molecules; 2014 Sep; 19(10):15546-71. PubMed ID: 25268714 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship studies of 2-(1,3,4-oxadiazole-2(3H)-thione)-3-amino-5-arylthieno[2,3-b]pyridines as inhibitors of DRAK2. Leonczak P; Gao LJ; Ramadori AT; Lescrinier E; Rozenski J; De Jonghe S; Herdewijn P ChemMedChem; 2014 Nov; 9(11):2587-601. PubMed ID: 25146684 [TBL] [Abstract][Full Text] [Related]
31. Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Wu B; Wang HL; Cee VJ; Lanman BA; Nixey T; Pettus L; Reed AB; Wurz RP; Guerrero N; Sastri C; Winston J; Lipford JR; Lee MR; Mohr C; Andrews KL; Tasker AS Bioorg Med Chem Lett; 2015 Feb; 25(4):775-80. PubMed ID: 25616902 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of benzofuro[3,2-b]pyridines via palladium-catalyzed dual C-H activation of 3-phenoxypyridine 1-oxides. Sun W; Wang M; Zhang Y; Wang L Org Lett; 2015 Feb; 17(3):426-9. PubMed ID: 25582123 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, Docking Study and Kinase Inhibitory Activity of a Number of New Substituted Pyrazolo[3,4-c]pyridines. Sklepari M; Lougiakis N; Papastathopoulos A; Pouli N; Marakos P; Myrianthopoulos V; Robert T; Bach S; Mikros E; Ruchaud S Chem Pharm Bull (Tokyo); 2017; 65(1):66-81. PubMed ID: 28049917 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of Thiazolo[5,4-f]quinazolin-9(8H)-ones as Multi-Target Directed Ligands of Ser/Thr Kinases. Hédou D; Godeau J; Loaëc N; Meijer L; Fruit C; Besson T Molecules; 2016 Apr; 21(5):. PubMed ID: 27144552 [TBL] [Abstract][Full Text] [Related]
36. Identification of 4-(2-furanyl)pyrimidin-2-amines as Janus kinase 2 inhibitors. Wang Y; Huang W; Xin M; Chen P; Gui L; Zhao X; Tang F; Wang J; Liu F Bioorg Med Chem; 2017 Jan; 25(1):75-83. PubMed ID: 27771180 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2. Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors. Ma S; Wang L; Ouyang B; Fan M; Qi J; Yao L Bioorg Med Chem; 2020 Oct; 28(19):115683. PubMed ID: 32912437 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2-a]pyridines derivatives as protein kinase inhibitors. Lawson M; Rodrigo J; Baratte B; Robert T; Delehouzé C; Lozach O; Ruchaud S; Bach S; Brion JD; Alami M; Hamze A Eur J Med Chem; 2016 Nov; 123():105-114. PubMed ID: 27474927 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents. Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]